Indiana University announced on Monday (Jun. 8) that Molly Duman Scheel, adjunct associate professor of biological sciences at the University of Notre Dame and associate professor of medical and molecular genetics at the Indiana University School of Medicine-South Bend (IUSM-SB), is a Grand Challenges Explorations winner, an initiative funded by...

University of Notre Dame researcher Mike Ferdig is part of team of researchers who have demonstrated that so-called “humanized” mice can be an effective model to study parasites that cause malaria and resistance to malarial drugs. Their study appears in the June 1 edition of the journal Nature Methods.

Michael Cosiano is one of several undergraduates working in Dr. Brian Baker's lab. The Baker lab focuses on the biophysics and structural biology of T- cell communication, and Michael is making important contributions to this work. Immunology is an incredibly important field linked to cancer research, and by furthering our...

On May 27 (Wednesday), Gregory P. Crawford, William K. Warren Dean of the College of Science and professor of physics at the University of Notre Dame, will embark on his fifth cross-country bicycle ride to raise awareness and funds for rare disease research at Notre Dame. Read more...

Rich Taylor, a member of the University of Notre Dame faculty since 1995, is a professor of chemistry and biochemistry in the College of Science. Taylor, who also serves as associate vice president for research at the University, has recently been appointed as interim director of the Warren Family Research...

Contributions to cancer research can take many forms and fall under various disciplines. Using analytical chemistry is important for better understanding the organization and composition of molecules in tissues impacted by cancer. Colleen Riordan, a junior majoring in biochemistry, uses her chemistry and biology background to contribute to cancer research....

The National Institute of Allergy and Infectious Disease (NIAID), an arm of the National Institutes of Health (NIH), has renewed funding for VectorBase, a bioinformatics resource center based at the University of Notre Dame since 2004 that manages genomic information on arthropods and other invertebrates that transmit human pathogens.

A new study by Robert Stahelin, an adjunct associate professor of chemistry and biochemistry at the University of Notre Dame and an associate professor at the Indiana University School of Medicine-South Bend, as well as a member of Notre Dame’s Eck Institute for Global Health, investigates how the most abundant...

Reginald Hill, the Archibald Assistant Professor of Cancer Biology, has published an article, “Attacking Cancer at its Roots,” on the website Science 2034.  Science 2034 is an initiative from The Science Coalition that asks scientists, policy makers, and thought leaders to share what they think science will do for individuals,...

A team of University of Notre Dame scientists, in collaboration with researchers at the University of Connecticut, have announced the results of a new study on identifying potential targets for personalized cancer vaccines. The paper, “Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity,” was...

The University of Notre Dame and Feinstein Institute for Medical Research have announced a plan to collaborate on biomedical research projects, student training, joint conferences and other forms of academic exchange. The Feinstein Institute was founded in 1999 to host the research operations for the North Shore-LIJ Health System. As...

Zachary T. Schafer, Coleman Assistant Professor of Cancer Biology at the University of Notre Dame, has been awarded a Research Scholar Grant from the American Cancer Society (ACS).

The largest outbreak of the Ebola virus in history currently occurring in West Africa has raised fears that the disease may soon spread to the United States. However, a University of Notre Dame researcher who studies the virus believes that, while there are grounds for concern, there is no need...

When it comes to a cancer diagnosis, timing can be everything. An early diagnosis can make a big difference when it comes to treatment possibilities. Pancreatic Ductile Adenocarcinoma (PDAC) has a 5 year survival rate of 6% according to Dr. Reginald Hill, Archibald Assistant Professor of Cancer Biology at the...

Nearly 50 scientists gathered at the University of Notre Dame on Sunday and Monday for the Indiana-Illinois End Epithelial Ovarian Cancer Coalition (IIEEOCC) workshop, an effort to advance collaboration and research on a deadly form of cancer that affects over 20,000 women a year.   Read more....

A new paper by a team of researchers led by Zachary T. Schafer, Coleman Assistant Professor of Cancer Biology in the Department of Biological Sciences at the University of Notre Dame, offers important new insights into the role carcinoma-associated fibroblasts (CAFs) play in tumor biology. A number of recent studies...

The Research Like a Champion competition winners were recently announced at the Harper Cancer Research Institute’s third annual research day. The donor who sponsored the competition was so impressed by the pool of research projects that he generously decided to provide funding for three projects.

At the Harper Cancer Research Institute, Notre Dame professor Z. Basar Bilgicer has found a way to focus chemotherapy on cancer cells while leaving healthy cells untouched. By Michael Rodio ’12 | Apr. 23, 2014   In the fight against cancer, chemotherapy is…

Christina Cheng, Zoe Li, Valerie Verdun, and Rebecca Wingert…

Now that the human genome is sequenced, University of Notre Dame researchers are focusing on the study of the proteome, which is the protein content of an organism, tissue or cell. Bioanalytical chemist Norman Dovichi and molecular biologist Paul Huber have successfully tracked the changing patterns of protein expression during...